8-KEarnings & ResultsLeadership ChangesExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Jul 30, 2007)

Filed July 30, 2007For Securities:DXCM

Summary

This Form 8-K filing by DexCom, Inc. on July 30, 2007, primarily announces its financial results for the quarter ended June 30, 2007, and significant executive management changes. Investors should note the retirement of CFO Steven J. Kemper and the appointment of Jess Roper as Interim CFO. The company also disclosed several executive promotions, indicating a reshuffling and potential growth within its senior leadership team. While the filing itself incorporates a press release with financial results (Exhibit 99.01), the details of these results are not elaborated within the 8-K text. The focus of the filing is on the personnel changes and the compensation packages associated with these transitions, including stock options and salary adjustments for the newly appointed and promoted executives. These changes are presented as strategic moves to support the company's operations and growth.

Key Highlights

  • 1DexCom, Inc. filed a Form 8-K on July 30, 2007, to report financial results for the quarter ended June 30, 2007.
  • 2Steven J. Kemper has retired as Chief Financial Officer, effective July 31, 2007, with no disagreement with the company's accounting or reporting.
  • 3Jess Roper has been appointed as the Interim Chief Financial Officer, effective July 31, 2007, continuing his role as Director of Finance.
  • 4Mr. Roper's compensation includes a base salary increase to $140,000 and a stock option grant for 25,000 shares.
  • 5Three executive officers were promoted: Jorge Valdes to Senior Vice President of Operations, Steven R. Pacelli to Senior Vice President of Corporate Affairs, and John Riolo to Vice President of Quality Assurance.
  • 6Promoted executives received salary increases and stock option grants, with vesting over 48 months.
  • 7The filing includes press releases detailing the financial results, CFO transition, and executive promotions as exhibits.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to report DexCom, Inc.'s financial results for the quarter ended June 30, 2007, and to announce significant changes in its executive leadership team, including the retirement of the CFO and several executive promotions.

Steven J. Kemper retired as CFO. Jess Roper has been appointed as the Interim CFO. Mr. Kemper received a separation payment of $115,000 and will consult for three months. His stock options will have extended vesting and exercise periods.

The Interim CFO, Jess Roper, received a base salary increase to $140,000 and a stock option grant for 25,000 shares. Promoted executives Jorge Valdes, Steven R. Pacelli, and John Riolo received salary increases and significant stock option grants, with vesting periods typically over 48 months.

The detailed financial results for the quarter ended June 30, 2007, are expected to be contained within the press release filed as Exhibit 99.01 to this Form 8-K. The 8-K itself does not provide the specific financial figures.